RecruitingPhase 2NCT07456488
The Effect of 0.01% Atropine Eye Drops on Axial Length and Refraction in Myopic Children Compared to a Control Group
Sponsor
Liaquat National Hospital & Medical College
Enrollment
60 participants
Start Date
Jul 13, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
In this study, atropine 0.01% eye drops will be given to myopic children once at night daily for 6 months as compared to a control group to see the effect on axial length and refraction
Eligibility
Min Age: 4 YearsMax Age: 16 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a drug called Atropine 0.01% eye drops for people with focus on axial length. The study is currently recruiting participants at 1 location. People eligible for this study include aged 4 Years to 16 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGAtropine 0.01% eye drops
Eye drops atropine 0.01% given once nightly to group A for 6 months
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07456488